The division of Nuclear Medicine is responsible for all the diagnostic and in-vivo procedures with unsealed radioactive sources and therapy of benign thyroid pathology. Most of the daily workload is referral for diagnostic procedures from specialties at ocean road Hospital; which include Oncology clinics, Endocrinology, Orthopedics, and Urology As there are no Nuclear Medicine facilities available at primary and secondary level a significant number of referrals are from outside Ocean road Hospital. The referring hospitals include Muhimbili National Hospital, Lugalo military hospital, Amana, Mwananyamala and Temeke. Various community health centres, private practitioners and specialists in the private sector also refer patients.
Diagnosis and Therapeutic Activities
Nuclear medicine imaging procedures are noninvasive and, with the exception of intravenous injections, are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers, our diagnostic services involves:
1. Thyroid scan using TC-99m Pertechnetate
2. Renogram using TC-99m labeled DTPA
3. Static Kidney studies using TC-99m Labeled DMSA
4. Bone scan using TC-99m labeled MDP
5. Scintimammography using TC-99 labeled MIBI
6. Radiopharmaceuticals are imported from AMESHARM SOUTH AFRICA.
Nuclear medicine also offers therapeutic procedures, such as radioactive iodine (I-131) therapy that use small amounts of radioactive material to treat cancer and other medical conditions affecting the thyroid gland, as well as treatments for other cancers and medical conditions.
Therapeutic Services are:
The use Iodine 131 for ablation cancer of the Thyroid gland, treatment of uncontrolled Toxic goiter and Graves’s diseases. I-131 is also imported from AMESHARM SOUTH AFRICA.
In average approximately 1250 cases of diagnostic and 54 cases of therapy are attended each annually.
Nuclear Medicine Imaging
Nuclear medicine imaging non-invasively provides functional information at the molecular and cellular level that contributes to the determination of health status by measuring the uptake and turnover of target-specific radiotracers in tissue. These functional processes include tissue blood flow and metabolism, protein—protein interactions, expression of cell receptors in normal and abnormal cells, cell—cell interactions, neurotransmitter activity, cell trafficking and homing, tissue invasion, and programmed cell death. By providing information on these processes, nuclear medicine imaging offers a broad array of tools for probing normal and disease-related states of tissue function and response to treatment.
The Human Capacity:
Two Nuclear Medicine Physicians
One Trained Nuclear Medicin Physicist
Four Trained Nuclear Medicine Technologists